Pt(IV)-PROTAC Complexes with Synergistic Antitumor Activity and Enhanced Membrane Permeability

被引：0

作者：

Li, Cheng-xin ^{[1
,2
]}

Zou, Zhi-ru ^{[1
,2
]}

Xu, Shan ^{[1
,2
]}

Shi, Jia-hui ^{[1
,2
]}

Zou, Yong ^{[1
,2
]}

Yan, Ming ^{[1
,2
]}

Zhang, Xue-jing ^{[1
,2
]}

机构：

[1] Sun Yat Sen Univ, State Key Lab Antiinfect Drug Discovery & Dev, Guangzhou 510006, Peoples R China

[2] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab Chiral Mol & Drug Discovery, Guangzhou 510006, Peoples R China

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2025年

关键词：

NUCLEOTIDE EXCISION-REPAIR; ANTICANCER ACTIVITY; PLATINUM DRUGS; CANCER; DELIVERY; FLUDARABINE; INHIBITOR; PRODRUGS; PARP1;

D O I：

10.1021/acs.jmedchem.4c02909

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A class of Pt(IV)-PROTAC complexes was designed and synthesized with dual aims of inducing DNA strand damage and inhibiting DNA repair. These complexes showed good antiproliferative activity against a range of cancer cell lines. Enhanced intracellular uptake of platinum and PROTAC was observed. Multiple mechanisms of action were identified, including the induction of DNA damage, disruption of DNA repair, and activation of mitochondrial-dependent apoptosis. One of the Pt(IV)-PROTACs, CW-2, showed excellent antitumor activity in a xenograft mouse model. These results suggest that Pt(IV)-PROTAC represents a promising strategy for the development of novel antitumor therapeutics.

引用

页数：18

共 50 条

[31] Preparation of bis(5-phenyltetrazolato) Pt(II) and Pt(IV) analogues of transplatin and in vitro evaluation for antitumor activity
Perfahl, Stefanie
Bodtke, Anja
Pracharova, Jitka
Kasparkova, Jana
Brabec, Viktor
Cuadrado, Juan
Sturup, Stefan
Schulzke, Carola
Bednarski, Patrick J.
INORGANICA CHIMICA ACTA, 2017, 456 : 86 - 94
[32] ANTITUMOR-ACTIVITY ISOMERIC 1,2-DIAMINOCYCLOHEXANE PLATINUM(IV) COMPLEXES
SIDDIK, ZH
ALBAKER, S
THAI, G
KHOKHAR, AR
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1994, 120 (07) : 409 - 414
[33] Synthesis, characterization and in vitro antitumor activity of three organotin(IV) complexes with carbazole ligand
Ruan, Banfeng
Tian, Yupeng
Zhou, Hongping
Wu, Jieying
Hu, Rentao
Zhu, Chenhao
Yang, Jiaxiang
Zhu, Hailiang
INORGANICA CHIMICA ACTA, 2011, 365 (01) : 302 - 308
[34] SYNTHESIS AND ANTITUMOR-ACTIVITY OF 1,2-DIAMINOCYCLOHEXANE PLATINUM(IV) COMPLEXES
KHOKHAR, AR
ALBAKER, S
SIDDIK, ZH
JOURNAL OF INORGANIC BIOCHEMISTRY, 1994, 54 (01) : 39 - 47
[35] SYNTHESIS AND ANTITUMOR-ACTIVITY OF AMMINE AMINE PLATINUM(II) AND PLATINUM(IV) COMPLEXES
KHOKHAR, AR
DENG, YJ
ALBAKER, S
YOSHIDA, M
SIDDIK, ZH
JOURNAL OF INORGANIC BIOCHEMISTRY, 1993, 51 (03) : 677 - 687
[36] Synthesis, characterization, and antitumor activity of novel tumor-targeted platinum(IV) complexes
Zhong, Yunshuang
Jia, Chunyan
Zhang, Xinzhong
Liao, Xiali
Yang, Bo
Cong, Yanwei
Pu, Shaoping
Gao, Chuanzhu
APPLIED ORGANOMETALLIC CHEMISTRY, 2020, 34 (05)
[37] Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure–activity relationship modeling
Paola Gramatica
Ester Papa
Mara Luini
Elena Monti
Marzia B. Gariboldi
Mauro Ravera
Elisabetta Gabano
Luca Gaviglio
Domenico Osella
JBIC Journal of Biological Inorganic Chemistry, 2010, 15 : 1157 - 1169
[38] ANTITUMOR-ACTIVITY AND CROSS-RESISTANCE STUDIES WITH PT-ASCORBATO COMPLEXES
HRUBISKO, M
BALAZOVA, E
KISS, F
KOVACOVA, J
UJHAZY, V
NEOPLASMA, 1989, 36 (06) : 651 - 657
[39] Oxovanadium(IV) based hypocrellin B complexes with enhanced photodynamic activity
Sun, Yi
Zheng, Yue
Lei, Wan-Hua
Zhou, Qian-Xiong
Hou, Yuan-Jun
Zhang, Bao-Wen
Wang, Xue-Song
DALTON TRANSACTIONS, 2012, 41 (02) : 651 - 657
[40] Pt(<sc>ii</sc>) and Pt(<sc>iv</sc>) complexes with a major component of royal jelly as innovative antitumor drug candidates
Barbanente, Alessandra
Gandin, Valentina
Donati, Chiara
Pierro, Carmela Ilaria
Natile, Giovanni
Margiotta, Nicola
NEW JOURNAL OF CHEMISTRY, 2023, 47 (39) : 18386 - 18399

← 1 2 3 4 5 →